Celldex Therapeutics, Inc.
CLDXNasdaqCIK 744218HealthcareFiscal year ends Dec 31
Reports and events: 261 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2012-08-1008:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-12-004461 |
| 2012-08-0916:01 ET | 10-Q | Quarterly reportPeriod 2012-06-30 | 0001104659-12-056527 |
| 2012-06-1410:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-12-043506 |
| 2012-05-2418:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-12-039533 |
| 2012-05-0410:19 ET | 10-Q | Quarterly reportPeriod 2012-03-31 | 0001104659-12-032960 |
| 2012-05-0309:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-12-002467 |
| 2012-04-2409:10 ET | DEF 14A | Proxy statementPeriod 2012-06-13 | 0001047469-12-004633 |
| 2012-04-0316:30 ET | 8-K | 1.02 Termination of a material agreement | 0001104659-12-023622 |
| 2012-03-0812:46 ET | 10-K | Annual reportPeriod 2011-12-31 | 0001047469-12-002276 |
| 2012-03-0708:00 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-12-016044 |
| 2012-02-2416:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-12-012515 |
| 2012-02-2316:00 ET | 8-K | 8.01 Other events | 0001104659-12-012137 |
| 2011-11-0312:48 ET | 10-Q | Quarterly reportPeriod 2011-09-30 | 0001104659-11-060466 |
| 2011-11-0208:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-11-006271 |
| 2011-08-0414:20 ET | 10-Q | Quarterly reportPeriod 2011-06-30 | 0001104659-11-043630 |
| 2011-08-0307:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-11-004615 |
| 2011-07-0608:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-11-037897 |
| 2011-06-1615:39 ET | 8-K | 5.07 Shareholder vote results | 0001104659-11-035114 |
| 2011-05-1816:54 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-11-029985 |
| 2011-05-0512:45 ET | 10-Q | Quarterly reportPeriod 2011-03-31 | 0001104659-11-026190 |
| 2011-05-0408:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-11-002686 |
| 2011-04-2610:26 ET | DEF 14A | Proxy statementPeriod 2011-06-15 | 0001047469-11-004060 |
| 2011-03-0915:45 ET | 10-K | Annual reportPeriod 2010-12-31 | 0001047469-11-001901 |
| 2011-03-0308:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-11-001357 |
| 2011-01-0608:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-11-000565 |
| 2010-12-2316:02 ET | 10-Q/A | Quarterly report, amendedPeriod 2010-09-30 | 0001104659-10-064202 |
| 2010-12-2316:01 ET | 10-K/A | Annual report, amendedPeriod 2009-12-31 | 0001104659-10-064201 |
| 2010-11-0411:38 ET | 10-Q | Quarterly reportPeriod 2010-09-30 | 0001104659-10-055897 |
| 2010-11-0209:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-10-006410 |
| 2010-09-1612:50 ET | 8-K | 5.07 Shareholder vote results | 0001104659-10-048815 |
| 2010-09-0716:28 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001104659-10-047511 |
| 2010-08-0513:07 ET | 10-Q | Quarterly reportPeriod 2010-06-30 | 0001104659-10-042274 |
| 2010-08-0412:16 ET | DEF 14A | Proxy statementPeriod 2010-09-15 | 0001047469-10-006977 |
| 2010-08-0408:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-10-004681 |
| 2010-05-0614:54 ET | 10-Q | Quarterly reportPeriod 2010-03-31 | 0001104659-10-026329 |
| 2010-05-0408:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-10-002696 |
| 2010-03-3115:43 ET | 10-K/A | Annual report, amendedPeriod 2009-12-31 | 0001104659-10-017686 |
| 2010-03-3015:23 ET | 8-K | 9.01 Financial statements and exhibits | 0001104659-10-017296 |
| 2010-03-1216:19 ET | 10-K | Annual reportPeriod 2009-12-31 | 0001047469-10-002142 |
| 2010-03-0408:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-10-001399 |
| 2010-02-1610:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-10-007163 |
| 2010-01-2514:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-10-002734 |
| 2010-01-0812:56 ET | 8-K | 9.01 Financial statements and exhibits | 0001047469-10-000066 |
| 2009-12-3116:44 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-09-072181 |
| 2009-11-0613:46 ET | 10-Q | Quarterly reportPeriod 2009-09-30 | 0001104659-09-063266 |
| 2009-11-0613:15 ET | DEF 14A | Proxy statementPeriod 2009-12-16 | 0001047469-09-009714 |
| 2009-11-0407:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-09-007639 |
| 2009-10-2116:56 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001047469-09-009091 |
| 2009-10-0217:49 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-09-057375 |
| 2009-09-0416:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001157523-09-006356 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 19:04 ET. Listed shows no prices and gives no investment advice.